Introduction: The success of mRNA vaccines in combating COVID-19 has propelled RNA-based therapeutics into the spotlight, showing their immense potential in modern medicine. These groundbreaking vaccines, like Pfizer-BioNTech and Moderna, have demonstrated unprecedented efficacy and safety, delivering hope to a world grappling with infectious diseases. But while mRNA vaccines represent a landmark achievement, they are…
IDST Monthly Access Membership Required
You must be a IDST Monthly Access member to access this content.
IDST Pro Access Required
This analysis is part of IDST premium intelligence.
Subscribe to Continue ReadingAlready a member? Log in